Quality Control of Widely Used Therapeutic Recombinant Proteins by a Novel Real-Time PCR Approach

BACKGROUND: Existence of bacterial host-cell DNA contamination in biopharmaceutical products is a potential risk factor for patients receiving these drugs. Hence, the quantity of contamination must be controlled under the regulatory standards. Although different methods such as hybridization assays...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamnoon, Babak, Naserpour Farivar, Taghi, Kamyab, Ahmad Reza, Ilghari, Dariush, Khamesipour, Ali, Karimi Arzenani, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute of Iran 2016
Materias:
Full Length
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689282/
https://www.ncbi.nlm.nih.gov/pubmed/26047906
http://dx.doi.org/10.7508/ibj.2016.01.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689282/
https://www.ncbi.nlm.nih.gov/pubmed/26047906
http://dx.doi.org/10.7508/ibj.2016.01.008

Ejemplares similares